Terms: = Breast cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
33 results:
1. Distinct profiles of proliferating CD8+/tcf1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.
Ntostoglou K; Theodorou SDP; Proctor T; Nikas IP; Awounvo S; Sepsa A; Georgoulias V; Ryu HS; Pateras IS; Kittas C
Cancer Immunol Immunother; 2024 Feb; 73(3):46. PubMed ID: 38349444
[TBL] [Abstract] [Full Text] [Related]
2. Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8
Yu A; Hu J; Fu L; Huang G; Deng D; Zhang M; Wang Y; Shu G; Jing L; Li H; Chen X; Yang T; Wei J; Chen Z; Zu X; Luo J
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37802603
[TBL] [Abstract] [Full Text] [Related]
3. Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip model.
Lu Z; Miao X; Song Q; Ding H; Rajan SAP; Skardal A; Votanopoulos KI; Dai K; Zhao W; Lu B; Atala A
Theranostics; 2023; 13(14):4905-4918. PubMed ID: 37771785
[No Abstract] [Full Text] [Related]
4. Eribulin promotes proliferation of CD8
Shimizu T; Oba T; Oshi M; Ito KI
Breast Cancer Res Treat; 2024 Jan; 203(1):57-71. PubMed ID: 37733186
[TBL] [Abstract] [Full Text] [Related]
5. Spatial predictors of immunotherapy response in triple-negative breast cancer.
Wang XQ; Danenberg E; Huang CS; Egle D; Callari M; Bermejo B; Dugo M; Zamagni C; Thill M; Anton A; Zambelli S; Russo S; Ciruelos EM; Greil R; Győrffy B; Semiglazov V; Colleoni M; Kelly CM; Mariani G; Del Mastro L; Biasi O; Seitz RS; Valagussa P; Viale G; Gianni L; Bianchini G; Ali HR
Nature; 2023 Sep; 621(7980):868-876. PubMed ID: 37674077
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
8. Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis.
Hassing CMS; Nielsen DL; Knoop AS; Tvedskov THF; Kroman N; Lænkholm AV; Juhl CB; Kümler I
Crit Rev Oncol Hematol; 2023 Apr; 184():103952. PubMed ID: 36854373
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer cell-derived extracellular vesicles promote CD8
Xie F; Zhou X; Su P; Li H; Tu Y; Du J; Pan C; Wei X; Zheng M; Jin K; Miao L; Wang C; Meng X; van Dam H; Ten Dijke P; Zhang L; Zhou F
Nat Commun; 2022 Aug; 13(1):4461. PubMed ID: 35915084
[TBL] [Abstract] [Full Text] [Related]
10. hnf1a-AS1: A Tumor-associated Long Non-coding RNA.
Liu Y; Zhao F; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(21):1720-1729. PubMed ID: 35619319
[TBL] [Abstract] [Full Text] [Related]
11. Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network.
Hequet D; Hamy AS; Girard N; Laas E; Coussy F; Rouzier R; Preau M; Delrieu L; Dumas A; Reyal F
Support Care Cancer; 2022 Jul; 30(7):5991-5999. PubMed ID: 35396963
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
[TBL] [Abstract] [Full Text] [Related]
13. Bioinformatics analysis of key genes and potential mechanism in cadmium-induced breast cancer progression.
Wu F; Zhang Y; Chen X; Wang Y; Peng H; Zhang Z; Yang Y; Wang Q
Environ Sci Pollut Res Int; 2022 Feb; 29(8):11883-11892. PubMed ID: 34558042
[TBL] [Abstract] [Full Text] [Related]
14. Blocking Short-Form Ron Eliminates breast cancer Metastases through Accumulation of Stem-Like CD4+ T Cells That Subvert Immunosuppression.
Lai SA; Gundlapalli H; Ekiz HA; Jiang A; Fernandez E; Welm AL
Cancer Discov; 2021 Dec; 11(12):3178-3197. PubMed ID: 34330779
[TBL] [Abstract] [Full Text] [Related]
15. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract] [Full Text] [Related]
16. Silencing long non-coding RNA hnf1a-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
[TBL] [Abstract] [Full Text] [Related]
17. Genome-wide Association Analysis of Proinflammatory Cytokines and Gene-lifestyle Interaction for Invasive breast cancer Risk: The WHI dbGaP Study.
Jung SY; Scott PA; Papp JC; Sobel EM; Pellegrini M; Yu H; Han S; Zhang ZF
Cancer Prev Res (Phila); 2021 Jan; 14(1):41-54. PubMed ID: 32928877
[TBL] [Abstract] [Full Text] [Related]
18. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
[TBL] [Abstract] [Full Text] [Related]
19. Deletion of
Meng Q; Wang L; Lv Y; Wu J; Shi W
Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
[No Abstract] [Full Text] [Related]
20. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract] [Full Text] [Related]
[Next]
